granted

related words
preclude
withdraw
milestone
determines
covering
composition
impossible
avoid
relied
biopharmaceutical
allows
initiated
relevant
gsk
final
suspended
prohibition
designation
march
entering
related documents
788206--6/4/2010--EMPIRE_ENERGY_CORP
1030471--3/2/2009--UTSTARCOM_INC
1055726--3/31/2009--INOVIO_BIOMEDICAL_CORP
1055726--3/17/2008--INOVIO_BIOMEDICAL_CORP
1055726--3/16/2007--INOVIO_BIOMEDICAL_CORP
1055726--3/16/2006--INOVIO_BIOMEDICAL_CORP
1262976--8/27/2010--VISTAPRINT_N.V.
1375063--9/23/2010--SYNTHESIS_ENERGY_SYSTEMS_INC
1177845--6/9/2010--XPLORE_TECHNOLOGIES_CORP
1412067--5/6/2010--Oncothyreon_Inc.
716646--6/14/2010--CLINICAL_DATA_INC
1347178--3/15/2010--Vanda_Pharmaceuticals_Inc.
98720--3/16/2010--TOREADOR_RESOURCES_CORP
1069183--3/15/2010--TASER_INTERNATIONAL_INC
704328--2/3/2010--SOMANETICS_CORP
748015--1/25/2010--SEALY_CORP
1328003--3/29/2010--Redpoint_Bio_CORP
1390478--3/31/2010--RXI_PHARMACEUTICALS_CORP
1300514--3/1/2010--LAS_VEGAS_SANDS_CORP
1038277--3/31/2010--INTERNATIONAL_ISOTOPES_INC
related topics
{product, candidate, development}
{stock, price, share}
{property, intellectual, protect}
{regulation, change, law}
{product, liability, claim}
{provision, law, control}
{cost, contract, operation}
{investment, property, distribution}
{operation, international, foreign}
{customer, product, revenue}
{stock, price, operating}
{debt, indebtedness, cash}
{personnel, key, retain}
{interest, director, officer}
{control, financial, internal}
{competitive, industry, competition}
{regulation, government, change}
{tax, income, asset}
{financial, litigation, operation}
{loss, insurance, financial}